ストックスクリーナーアプリを入手
4.92
5.13%
0.24
アフターアワーズ：
4.92
Optimi Health Corp (OPTH) 最新ニュース
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
OPTH|Optimi Health Ord Shs|Price:4.680|Chg%:-0.070 - TradingKey
Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules - TMX Newsfile
3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Sahm
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart - mexc.co
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - AOL.com
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - AOL.com
Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. (OPTH) Stock: Surges 8% as Psilocybin Shipments to Australia Signal Growing Commercial Momentum - parameter.io
Optimi Health completes psilocybin export to Australia for patients with treatment-resistant depression - MSN
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - Financial Times
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD - Stock Titan
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewswire Inc.
Optimi Health completes third export of psilocy... - Pluang
Price to earnings forward of Optimi Health Corp. – CSE:OPTI - TradingView
Price to sales forward of Optimi Health Corp. – LSX:A411WC - TradingView
Optimi Health Corp. (OPTH) Cash From Operations (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Market Cap - Zacks Investment Research
Optimi Health (OPTH) Stock Trends and Sentiment 2026 - MarketBeat
OPTH|Optimi Health Ord Shs|Price:4.060|Chg%:0.05 - TradingKey
Price to book ratio of Optimi Health Corp. – TRADEGATE:8BN0 - TradingView
Optimi Health Corp. (OPTH) Book Value - Zacks Investment Research
Optimi Health Corp. (OPTH) Earnings Yield (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Price To Free Cash Flow - Zacks Investment Research
Optimi Health Corp. (OPTH) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Optimi Health Corp. (OPTH) Free Cash Flow (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Total Expenses (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Shareholders Equity (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Net Income (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Ps Ratio (TTM) - Zacks Investment Research
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GuruFocus
Inside the new tiny-dose psilocybin pills labs will test in studies - Stock Titan
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
Optimi Health completes production of microdose psilocybin products By Investing.com - Investing.com Nigeria
Optimi Health completes production of microdose psilocybin products - Investing.com
Optimi Health (NASDAQ: OPTH) debuts standardized psilocybin microdose capsules for research - Stock Titan
Optimi Health launches 1mg and 2mg microdose ps... - Pluang
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com India
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):